EUVIMEDEUVIMED entdecken
Leserbrief

Anti‐ Ro52 seropositivity as a diagnostic pitfall in myositis‐specific/associated antibody panels after intravenous immunoglobulin: Direct evidence from product and paired patient sera

Rafaella do Amaral Barbosa iD, Samuel Katsuyuki Shinjo iD

Vox Sanguinis · 09.11.2026

DOI: 10.1111/vox.70420 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Vox Sanguinis, online erschienen am 09.11.2026. Verfasst von Rafaella do Amaral Barbosa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, São Paulo, Brazil. Die Arbeit nennt 10 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, São Paulo, Brazil.

ORCID-Profile: Rafaella do Amaral Barbosa, Samuel Katsuyuki Shinjo

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Barbosa, R. D. A., & Shinjo, S. K. (2026). Anti‐ Ro52 seropositivity as a diagnostic pitfall in myositis‐specific/associated antibody panels after intravenous immunoglobulin: Direct evidence from product and paired patient sera. Vox Sanguinis. https://doi.org/10.1111/vox.70420

Vancouver

Barbosa RDA, Shinjo SK. Anti‐ Ro52 seropositivity as a diagnostic pitfall in myositis‐specific/associated antibody panels after intravenous immunoglobulin: Direct evidence from product and paired patient sera. Vox Sanguinis. 2026. doi:10.1111/vox.70420

BibTeX
@article{Barbosa2026,
  author = {Barbosa, Rafaella do Amaral and Shinjo, Samuel Katsuyuki},
  title = {Anti‐ Ro52 seropositivity as a diagnostic pitfall in myositis‐specific/associated antibody panels after intravenous immunoglobulin: Direct evidence from product and paired patient sera},
  journal = {Vox Sanguinis},
  year = {2026},
  doi = {10.1111/vox.70420}
}
Kostenlos starten →